Restless revelations - Unveiling Uncommon Occurrence of Cariprazine-Induced Akathisia.
作者信息
Nandish M, Agrawal Mohit, Chauhan Vinay S
机构信息
Department of Psychiatry, Armed Forces Medical College, Pune, Maharashtra, India.
Department of Psychiatry, Command Hospital (Southern Command), Pune, Maharashtra, India.
出版信息
Ind Psychiatry J. 2025 May-Aug;34(2):356-357. doi: 10.4103/ipj.ipj_325_24. Epub 2025 Jul 18.
Abstract
摘要
相似文献
1
Restless revelations - Unveiling Uncommon Occurrence of Cariprazine-Induced Akathisia.不安的揭示——揭示卡立普嗪诱发静坐不能的罕见情况
Ind Psychiatry J. 2025 May-Aug;34(2):356-357. doi: 10.4103/ipj.ipj_325_24. Epub 2025 Jul 18.
2
Medication-Induced Akathisia with Newly Approved Antipsychotics in Patients with a Severe Mental Illness: A Systematic Review and Meta-Analysis.新型抗精神病药物致严重精神障碍患者药物性静坐不能的系统评价和 Meta 分析。
CNS Drugs. 2019 Jun;33(6):549-566. doi: 10.1007/s40263-019-00625-3.
3
Cariprazine and akathisia, restlessness, and extrapyramidal symptoms in patients with bipolar depression.卡利拉嗪与双相抑郁症患者的静坐不能、不安和锥体外系症状。
J Affect Disord. 2021 Jun 1;288:191-198. doi: 10.1016/j.jad.2021.03.076. Epub 2021 Mar 31.
4
The efficacy and tolerability of cariprazine in acute mania associated with bipolar I disorder: a phase II trial.卡立普嗪治疗伴有双相I型障碍的急性躁狂症的疗效和耐受性：一项II期试验
Bipolar Disord. 2015 Feb;17(1):63-75. doi: 10.1111/bdi.12238. Epub 2014 Jul 24.
5
The safety and tolerability of cariprazine in long-term treatment of schizophrenia: a post hoc pooled analysis.卡立普嗪长期治疗精神分裂症的安全性和耐受性：一项事后汇总分析。
BMC Psychiatry. 2017 Aug 24;17(1):305. doi: 10.1186/s12888-017-1459-z.
6
Safety and Tolerability of Cariprazine in Patients with Schizophrenia: A Pooled Analysis of Eight Phase II/III Studies.卡立普嗪在精神分裂症患者中的安全性和耐受性：八项II/III期研究的汇总分析
Neuropsychiatr Dis Treat. 2021 Apr 7;17:957-970. doi: 10.2147/NDT.S301225. eCollection 2021.
7
Tolerability and Safety Profile of Cariprazine in Treating Psychotic Disorders, Bipolar Disorder and Major Depressive Disorder: A Systematic Review with Meta-Analysis of Randomized Controlled Trials.卡立普嗪治疗精神障碍、双相情感障碍和重度抑郁症的耐受性和安全性概况：一项随机对照试验的系统评价与荟萃分析
CNS Drugs. 2016 Nov;30(11):1043-1054. doi: 10.1007/s40263-016-0382-z.
8
Role of adjunctive cariprazine for treatment-resistant depression in patients with major depressive disorder: A systematic review and meta-analysis of randomized controlled trials.辅助卡利拉嗪治疗伴有或不伴有精神分裂症的重性抑郁障碍患者的疗效和安全性的网状meta 分析
Asian J Psychiatr. 2024 May;95:104005. doi: 10.1016/j.ajp.2024.104005. Epub 2024 Mar 11.
9
Efficacy and safety of low- and high-dose cariprazine in acute and mixed mania associated with bipolar I disorder: a double-blind, placebo-controlled study.卡利拉嗪低、高剂量治疗与双相 I 型障碍相关的急性和混合躁狂的疗效和安全性：一项双盲、安慰剂对照研究。
J Clin Psychiatry. 2015 Mar;76(3):284-92. doi: 10.4088/JCP.14m09081.
10
The safety and tolerability of cariprazine in patients with manic or mixed episodes associated with bipolar I disorder: A 16-week open-label study.卡利拉嗪治疗伴有或不伴有双相 I 型障碍躁狂或混合发作患者的安全性和耐受性：一项为期 16 周的开放标签研究。
J Affect Disord. 2018 Jan 1;225:350-356. doi: 10.1016/j.jad.2017.08.040. Epub 2017 Aug 18.
本文引用的文献
1
The Assessment and Treatment of Antipsychotic-Induced Akathisia.抗精神病药物所致静坐不能的评估与治疗
Can J Psychiatry. 2018 Nov;63(11):719-729. doi: 10.1177/0706743718760288. Epub 2018 Apr 23.
2
Revisiting Antipsychotic-induced Akathisia: Current Issues and Prospective Challenges.重新审视抗精神病药物所致静坐不能：当前问题与未来挑战
Curr Neuropharmacol. 2017;15(5):789-798. doi: 10.2174/1570159X14666161208153644.
3
Cariprazine: chemistry, pharmacodynamics, pharmacokinetics, and metabolism, clinical efficacy, safety, and tolerability.卡利拉嗪：化学、药效学、药代动力学和代谢、临床疗效、安全性和耐受性。
Expert Opin Drug Metab Toxicol. 2013 Feb;9(2):193-206. doi: 10.1517/17425255.2013.759211.
Zotero 插件